| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 15,666,800 | 15,553,700 | 15,561,400 | 15,233,900 | | Cost of Revenue | (118,900) | 118,900 |
-
|
-
| | | Gross Profit | 15,785,700 | 15,434,800 | 15,561,400 | 15,233,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,411,600 | 14,365,100 | 14,038,100 | 13,669,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 71,600 | 71,500 | 75,200 | 73,800 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,302,500 | 998,200 | 1,448,100 | 1,491,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,302,500 | 998,200 | 1,448,100 | 1,491,000 | | Interest Expense | 116,500 | 119,000 | 125,300 | 119,600 | | Income Before Tax | 1,186,000 | 879,200 | 1,322,800 | 1,371,400 | | Income Tax Expense | 435,500 | 291,100 | 463,700 | 503,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 750,500 | 588,100 | 859,100 | 868,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 750,500 | 588,100 | 859,100 | 868,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $750,500 | $588,100 | $859,100 | $868,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
